Company / Working Capital
ARDELYX, INC. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$293.7M
FY2025
5-year range
$80.8M / $293.7M
FY2021-FY2025
Trend
+5.4%
vs FY2024
Sector context
#144 of 213
Health Care
What the data says
At $294M, ARDELYX, INC.'s working capital ranks #144 of 213 in the Health Care sector. Working Capital has increased for 4 consecutive years, from $81M in FY2021 to $294M in FY2025.
Based on SEC 10-K filings.
$294M in FY2025 with a 5-year CAGR of +12.1%.
Improved from $196M to $294M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +49.4%
- 5-Year CAGR
- +12.1%
- 10-Year CAGR
- -
Sector benchmark
#144 of 213 in Health CareTop 68% of 213This company $293.7M Sector average $934.6M
▼
-68.6% below sector average
Key checks
Key Insights
- ARDELYX, INC.'s working capital has grown for 4 consecutive years.
- 5-year CAGR of +12.1%, indicating consistent growth.
- In FY2025, working capital increased 5.4% year-over-year.
- Ranks #144 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $293.7M | +5.4% |
| FY2024 | $278.6M | +42.4% |
| FY2023 | $195.7M | +122.4% |
| FY2022 | $88.0M | +8.9% |
| FY2021 | $80.8M | -51.4% |
| FY2020 | $166.3M | -27.7% |
| FY2019 | $229.8M | +44.9% |
| FY2018 | $158.6M | +20.3% |
| FY2017 | $131.8M | -28.7% |
| FY2016 | $184.8M | +77.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026